Dr Tatiane Vilaca

MD, PhD

School of Medicine and Population Health

Postdoctoral Research Associate

Dr Tatiane Vilaca
Dr Tatiane Vilaca
Profile picture of Dr Tatiane Vilaca
t.vilaca@sheffield.ac.uk
+44 114 215 5701
Metabolic Bone Centre, Northern General Hospital

Full contact details

Dr Tatiane Vilaca
School of Medicine and Population Health
Metabolic Bone Centre
Northern General Hospital
Herries Road
Sheffield
S5 7AU
Profile

I graduated from Medical School and trained in Endocrinology and Diabetes at the Federal University of Minas Gerais (UFMG) in Brazil. I undertook a research Master’s in Translational Medicine at the Federal University of Sao Paulo (EPM-UNIFESP) and completed my PhD at the University of Sheffield. During my PhD, I studied bone health in diabetes. Since completing my PhD, I have worked as a Postdoctoral Research Associate at the University of Sheffield.

Research interests

I am interested in the effects of chronic diseases and medications on bone and the underlying mechanisms. I have vast experience in systematic reviews, with several publications on the effect of chronic diseases on the risk of fractures. I have led four systematic reviews, three on the risk of fractures in diabetes and chronic kidney disease and another on osteomalacia following repeated iron infusions. I have also participated in other reviews, investigating the risk of fractures in Parkinson’s disease and microRNA profile in sarcopenia and obesity. These projects result from several collaborations within the University of Sheffield (e.g., ScHARR) and international groups from the USA and Denmark.

I am particularly interested in the effects of diabetes and obesity on bone health. I investigated several aspects of bone health in this diabetes, including microarchitecture using high-resolution peripheral quantitative computed tomography, the effects of neuropathy and other potential mechanisms associated with bone fragility in this disease, such as the role of advanced glycation end products (AGEs). I have also investigated the endocrine mechanisms associated with favourable bone structure in obesity and the interplay between fat and bone.

Recently, I have worked on a family mapping study in hypophosphatasia (HPP), the FAME study, in collaboration with the Sheffield Children’s Hospital. I characterise musculoskeletal features and mineral metabolism in people with HPP, a rare bone disease.

I am involved in the FNIH-ASBMR-SABRE Project (Study to Advance BMD as a Regulatory Endpoint). This multidisciplinary international initiative aims to change the regulation on the requirements for osteoporosis drug approval from reduction in clinical fractures to treatment-related changes in BMD, which would encourage the development of new drugs.

Publications

Show: Featured publications All publications

Journal articles

  • Walle M, Duseja A, Whittier DE, Vilaca T, Paggiosi M, Eastell R, Müller R & Collins CJ (2024) . Journal of Bone and Mineral Research, 39(2), 85-94.
  • Vilaca T & Eastell R (2024) . Current Osteoporosis Reports, 22, 1-10.
  • Vilaca T & Eastell R (2023) . JBMR Plus, 7(11).
  • Vilaca T, Evans A, Gossiel F, Paggiosi M, Eastell R & Walsh JS (2022) . European Journal of Endocrinology, 187(6), 743-750.
  • Vilaca T, Velmurugan N, Smith C, Abrahamsen B & Eastell R (2022) . Journal of Bone and Mineral Research, 37(6), 1188-1199.
  • Vilaca T, Eastell R & Schini M (2022) . Lancet Diabetes & Endocrinology, 10(4), 273-283.
  • Vilaca T, Paggiosi M, Walsh JS, Selvarajah D & Eastell R (2021) . Journal of Bone and Mineral Research, 36(6), 1048-1059.
  • Vilaca T, Salam S, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR & Eastell R (2020) . American Journal of Kidney Diseases, 76(4), 521-532.
  • Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR & Eastell R (2020) . Bone, 137.
  • Vilaca T, Walsh J & Eastell R (2019) . Osteoporosis International, 30(1), 135-143.

All publications

Journal articles

  • Vilaca T, Gossiel F, Eastell R & Balasubramanian M (2025) . Journal of the Endocrine Society, 9(Supplement_1).
  • Vilaca T, Lui L-Y, Schini M, Ewing S, Thompson AR, Vittinghoff E, Bauer D, Bauer D, Black DM, Bouxsein M & Eastell R (2025) . Journal of the Endocrine Society, 9(Supplement_1).
  • Vilaca T, Lui L-Y, Schini M, Ewing SK, Thompson A, Vittinghoff E, Bauer DC, Black DM, Bouxsein ML & Eastell R (2025) . Journal of Bone and Mineral Research.
  • Vilaca T, Gossiel F, Delaney S, Baker D, Keigwin S, Eastell R & Balasubramanian M (2025) . JBMR Plus, 9(5).
  • Schini M, Lui L-Y, Vilaca T, Ewing SK, Thompson A, Bauer DC, Bouxsein ML, Black DM & Eastell R (2025) . Journal of Bone and Mineral Research, 40(3), 307-314.
  • Schini M, Gossiel F, Saini T, Banda P, Ward R, Vilaca T, Eastell R & Fontalis A (2025) . Journal of Bone and Mineral Research, 40(3).
  • Vilaca T, Schini M, Lui L-Y, Ewing SK, Thompson AR, Vittinghoff E, Bauer DC, Eastell R, Black DM & Bouxsein ML (2024) . Journal of Bone and Mineral Research, 39(10), 1434-1442.
  • Schini M, Vilaca T, Lui L-Y, Ewing SK, Thompson A, Vittinghoff E, Bauer DC, Bouxsein ML, Black DM & Eastell R (2024) . Journal of Bone and Mineral Research, 39(7), 867-876.
  • Schini M, Vilaca T, Vittinghoff E, Lui L-Y, Ewing SK, Thompson AR, Bauer DC, Bouxsein ML, Black DM & Eastell R (2024) . Journal of Bone and Mineral Research, 39(5), 544-550.
  • Walle M, Duseja A, Whittier DE, Vilaca T, Paggiosi M, Eastell R, Müller R & Collins CJ (2024) . Journal of Bone and Mineral Research, 39(2), 85-94.
  • Vilaca T & Eastell R (2024) . Current Osteoporosis Reports, 22, 1-10.
  • Vilaca T & Eastell R (2023) . JBMR Plus, 7(11).
  • Schini M, Vilaca T, Gossiel F, Salam S & Eastell R (2023) . Endocrine Reviews, 44(3), 417-473.
  • Vilaca T, Evans A, Gossiel F, Paggiosi M, Eastell R & Walsh JS (2022) . European Journal of Endocrinology, 187(6), 743-750.
  • Albergaria B-H, Zerbini CAF, Szejnfeld VL, Eis SR, Silva DMW, de Fatima Lobato da Cunha M, McClung MR, Kanis JA, McCloskey EV, Vilaca T & Lazaretti-Castro M (2022) . Archives of Osteoporosis, 17(1).
  • Vilaca T, Velmurugan N, Smith C, Abrahamsen B & Eastell R (2022) . Journal of Bone and Mineral Research, 37(6), 1188-1199.
  • Vilaca T, Eastell R & Schini M (2022) . Lancet Diabetes & Endocrinology, 10(4), 273-283.
  • Dowling L, Duseja A, Vilaca T, Walsh JS & Goljanek‐Whysall K (2022) . Journal of Cachexia, Sarcopenia and Muscle, 13(1), 68-85.
  • Vilaca T, Paggiosi M, Walsh JS, Selvarajah D & Eastell R (2021) . Journal of Bone and Mineral Research, 36(6), 1048-1059.
  • Vilaca T, Gossiel F, Selvarajah D & Eastell R (2021) . Bone Reports, 14, 100869-100869.
  • Vilaca T, Paggiosi M, Walsh J, Selvarajah D & Eastell R (2020) . Bone Reports, 13.
  • Vilaca T, Salam S, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR & Eastell R (2020) . American Journal of Kidney Diseases, 76(4), 521-532.
  • Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR & Eastell R (2020) . Bone, 137.
  • Vilaca T, Walsh J & Eastell R (2019) . Osteoporosis International, 30(1), 135-143.

Conference proceedings

  • Vilaca T, Velmurugan N, Smith C, Abrahamsen B & Eastell R (2022) . Bone Reports, Vol. 16(supplement). Helsinki, Finland, 7 May 2022 - 10 May 2022.
  • Duseja A, Dowling L, Vilaca T, Eastell R & Hackl M (2022) MicroRNAs in Diabetic Bone Disease: a Systematic Review. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 177-177)
  • Vilaca T, Gossiel F, Schalkwijk C, Walsh J, Selvarajah D & Eastell R (2022) Association of Bone Turnover Markers and Advanced Glycation End Products in Type 1 Diabetes. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 79-79)
Grants

Royal Osteoporosis Society Early Career grant in 2021.

I was awarded the American Society for Bone and Mineral Research ASBMR Young Investigator award in 2019.

Teaching interests

I am an Associate Fellow of the HEA. I regularly supervise SSC students and placement students in our group.

Professional activities and memberships

I am an Associate Fellow of the Higher Education Academy.

Current projects

The FAME study: family mapping in hypophosphatasia We aim to characterise HPP musculoskeletal symptoms, mineral metabolism abnormalities, and the impact on quality of life.

The FNIH-ASBMR-SABRE Project (Study to Advance BMD as a Regulatory Endpoint) We aim to change the regulation on the requirements for osteoporosis drug approval from reduction in clinical fractures to treatment-related changes in BMD.

Exploring the effects of anti-resorptive and anabolic treatment in serum advanced glycation end products (AGEs)